• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,716.11 191.85
( 0.26%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
65,160.26 1,135.66
(1.77%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

Indoco Remedies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532612
INE873D01024
119.0842677
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDOCO
0
1844.23
EPS(TTM)
Face Value()
Div & Yield %
0
2
0.1
 

As on: Jun 09, 2026 02:05 PM

Last Price() Net Change (%) Volume (Nos) P / E
201.45 1.65 10305 0.00
Stock Price Details
Open Price() 203.90
Best Buy () 200.4
Best Sell () 201.45
Buy Quantity (Nos) 50
Sell Quantity (Nos) 214
Today's High () 205.40
Today's Low () 199.50
52-Week High () 348.1
152-Week Low () 163.7
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.10
Eps 0
Book Value 119.0842677
Market Cap (.Cr) 1,844.23
Face Value 2
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE873D01024


News
Indoco Remedies climbs after Baddi plant secures EU GMP certification; ICICI Prudential MF buys 1.47% stake
Indoco Remedies receives EU GMP certification from Malta Medicines Authority
Board of Indoco Remedies recommends Final Dividend
Indoco Remedies reports consolidated net loss of Rs 21.64 crore in the March 2026 quarter
Indoco Remedies gains after reporting turnaround Q4 performance
Indoco Remedies to announce Quarterly Result & final dividend
Indoco Remedies rises on USFDA approval for Brivaracetam oral solution
Indoco Remedies allots 55,700 equity shares under ESOP
Indoco Remedies reports consolidated net loss of Rs 29.79 crore in the December 2025 quarter
Indoco Remedies receives USFDA approval for Lacosamide Oral Solution
More
Corporate Details
Incoporation Year   : 1947
Chairman : Suresh G Kare
Bussiness Group : Indian Private
Registered Office
Indoco Remedies Ltd
Indoco House 166 C S T Road,
Santacruz (East) Kalina,
Mumbai,
Maharashtra-400098
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-26541851-55
Fax:91-022-26520787
Fax:91-22-66317458
E-Mail : compliance.officer@indoco.com
URL : http://www.indoco.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE HC
  • BSE SmallCap
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi